Miroslaw Mazurczak

Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study

Bret B. Friday, S. K. Anderson, J. Buckner et al. · Neuro-Oncology · 2011 · 210 citations · Full text

The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial

Lisa A. Kottschade, Jeff A. Sloan, Miroslaw Mazurczak et al. · Supportive Care in Cancer · 2010 · 172 citations · Full text

Vitamin E, Neuro-oncology, Medicine +7

A phase II trial of Triapine® (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503

Anne M. Traynor, Ju-Whei Lee, Gerald K. Bayer et al. · Investigational New Drugs · 2009 · 110 citations · Full text

Second Line Treatment, Oncology, Phase Ii Trial +8

Evaluation of shark cartilage in patients with advanced cancer

Charles L. Loprinzi, Ralph Levitt, Debra L. Barton et al. · Cancer · 2005 · 97 citations

Doxepin Rinse Versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy With or Without Chemotherapy: A Phase III, Randomized, Double-Blind Trial (NCCTG-N09C6 [Alliance])

James L. Leenstra, Robert C. Miller, Rui Qin et al. · Journal of Clinical Oncology · 2014 · 88 citations · Full text